These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26070873)

  • 1. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
    Jang BG; Lee BL; Kim WH
    Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Luo Z; Zhang Q; Zhao Z; Li B; Chen J; Wang Y
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1713-20. PubMed ID: 21904905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
    Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
    Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.
    Qin R; Wang NN; Chu J; Wang X
    World J Gastroenterol; 2012 Jul; 18(25):3296-302. PubMed ID: 22783055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer.
    Ran X; Xu X; Yang Y; She S; Yang M; Li S; Peng H; Ding X; Hu H; Hu P; Zhang D; Ren H; Wu L; Zeng W
    Int J Oncol; 2015 Nov; 47(5):1932-44. PubMed ID: 26398045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
    Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway.
    Zhou DS; Zhang WJ; Song SY; Hong XX; Yang WQ; Li JJ; Xu JQ; Kang JY; Cai TT; Xu YF; Guo SJ; Pan HF; Li HW
    World J Gastrointest Oncol; 2024 Jul; 16(7):3211-3229. PubMed ID: 39072182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
    Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
    Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of olfactomedin-4 in extrahepatic bile duct carcinoma.
    Jun SY; An S; Huh T; Chung JY; Hong SM
    Pathol Res Pract; 2020 May; 216(5):152940. PubMed ID: 32276789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
    Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
    Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.
    Suh YS; Lee HJ; Jung EJ; Kim MA; Nam KT; Goldenring JR; Yang HK; Kim WH
    Ann Surg Oncol; 2012 Apr; 19(4):1240-9. PubMed ID: 22048633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of olfactomedin 4 as a molecular biomarker for early diagnosis of gastric neoplasia after intestinal metaplasia.
    Pang L; Yan X; Su D; Wu X; Jiang H
    Scand J Gastroenterol; 2023 Feb; 58(2):133-141. PubMed ID: 36124708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer.
    Wang D; Li T; Ye G; Shen Z; Hu Y; Mou T; Yu J; Li S; Liu H; Li G
    PLoS One; 2015; 10(4):e0122697. PubMed ID: 25860956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients.
    Lian Y; Sang M; Gu L; Liu F; Yin D; Liu S; Huang W; Wu Y; Shan B
    Pathol Res Pract; 2017 Aug; 213(8):943-948. PubMed ID: 28647208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.